ADIAL PHARMACEUTICALS, INC. Common Stock Shares Outstanding

Quick Answer

ADIAL PHARMACEUTICALS, INC. reported Common Stock Shares Outstanding of 1.11 million shares for the year ending 2025.

  • ADIAL PHARMACEUTICALS, INC. showed an increase of +329.2% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from ADIAL PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
  • XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2017 to 2025), ADIAL PHARMACEUTICALS, INC.'s Common Stock Shares Outstanding has declined by 66.0%.
  • Historical annual values: Fiscal year 2025: 1.11 million shares | Fiscal year 2024: 258,826 shares | Fiscal year 2023: 1.66 million shares | Fiscal year 2022: 1.07 million shares | Fiscal year 2021: 20.95 million shares | Fiscal year 2020: 14.39 million shares | Fiscal year 2019: 10.37 million shares | Fiscal year 2018: 6.86 million shares | Fiscal year 2017: 3.27 million shares.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: